Share
Journal Information
Special content about coronavirus SARS-CoV-2 (COVID-19) in Reumatología Clínica (English Edition)
Characteristics of patients with immune-mediated inflammatory diseases hospitalized for SARS-CoV-2 infection
Montserrat Robustillo-Villarino, Laura Álvarez-Arroyo, Francisco Javier Carrera-Hueso, Inés Barreda-Altaba, María Nieto-Cid, Ana María Girona-Sanz, David El-Qutob
10.1016/j.reumae.2021.03.005
Reumatol Clin. 2022;18:331-7
Open Article
Teleconsultation of infant rheumatology in Covid-19 time
Juan Carlos Nieto-González, Indalecio Monteagudo
10.1016/j.reumae.2020.09.004
Reumatol Clin. 2022;18:379-80
Open Article
Calcineurin Inhibitors and COVID-19
René Hage, Macé M. Schuurmans
10.1016/j.reumae.2020.09.007
Reumatol Clin. 2022;18:314-5
Open Article
Impact of the COVID-19 pandemic on rheumatology nursing consultation
Susana P. Fernández Sánchez, Fermín Rodríguez Muñoz, Ana Laiz, Ivan Castellví, Berta Magallares, Héctor Corominas
10.1016/j.reumae.2021.02.001
Reumatol Clin. 2022;18:231-5
Open Article
Experience With the Use of Baricitinib and Tocilizumab Monotherapy or Combined, in Patients With Interstitial Pneumonia Secondary to Coronavirus COVID19: A Real-World Study
José Rosas, Francisco Pasquau Liaño, Mónica Llombart Cantó, José María Carrasco Barea, Amparo Raga Beser, José Tomás Algado Rabasa, Francisco Martínez Adsuar, Brian Vila Auli, Isabel Fernández López, Ana María Garijo Sainz, Pere Esquerdo Ramis, Laura Ruiz Pérez, Mª Luisa Navarrete Rebollo, Raquel Hernández Lorido, Laura Gómez Escolar
10.1016/j.reumae.2020.10.006
Reumatol Clin. 2022;18:150-6
Open Article
Tele-Rheumatology during the COVID-19 pandemic
Jesús Tornero-Molina, Fernando Sánchez-Alonso, Manuel Fernández-Prada, María-Luisa Bris-Ochaita, Alberto Sifuentes-Giraldo, Javier Vidal-Fuentes
10.1016/j.reumae.2020.10.002
Reumatol Clin. 2022;18:157-63
Open Article
Inflammatory response in relation to COVID-19 and other prothrombotic phenotypes
José A. Páramo
10.1016/j.reumae.2020.06.007
Reumatol Clin. 2022;18:1-4
Open Article
Reumataxi: An experience of solidarity in times of COVID-19
Josep Blanch-Rubió, Jone Llorente-Onaindia, Pere Benito, Jordi Monfort
10.1016/j.reumae.2020.04.002
Reumatol Clin. 2022;18:61
Open Article
Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab
Luis Figuero-Pérez, Alejandro Olivares-Hernández, Roberto A. Escala-Cornejo, Eduardo Terán-Brage, Álvaro López-Gutiérrez, Juan J. Cruz-Hernández
10.1016/j.reumae.2020.06.008
Reumatol Clin. 2021;17:559-61
Open Article
Why choose cyclosporin A as first-line therapy in COVID-19 pneumonia
Olga Sanchez-Pernaute, Fredeswinda I. Romero-Bueno, Albert Selva-O’Callaghan
10.1016/j.reumae.2020.03.005
Reumatol Clin. 2021;17:556-7
Open Article
Special content about COVID-19
- Spontaneous pneumomediastinum: An extra muscular manifestation of anti-MDA5 dermatomyositis. Report of 2 cases
- The impact of COVID-19 and other factors on the usage status of the biologic drug therapies for rheumatoid arthritis: A study from Vietnam
- Analysis of factors involved in the development of humoral response to vaccination against SARS-CoV-2 in patients with rheumatic pathology under biological treatment
- The “autoimmune/inflammatory syndrome induced by adjuvants” (ASIA) after COVID-19 infection: A case report
Publish in
Reumatología Clínica